十一月 2025
- Home
- Valeant Pharmaceuticals
十一月 2025的Valeant Pharmaceuticals市场份额分析
Learn about Bausch Health, a global company whose mission is to improve people’s lives with our health care products.
Valeant Pharmaceuticals(包含公司地区分支机构)
查看更多网站流量和参与度信息- valeant.com
Valeant Pharmaceuticals热门域名的总访问量
了解Valeant Pharmaceuticals市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
无数据可显示
无数据可显示
Valeant Pharmaceuticals热门域名的平均访问时长
分析Valeant Pharmaceuticals参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
Valeant Pharmaceuticals热门域名的平均页面浏览量
了解Valeant Pharmaceuticals如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
无数据可显示
无数据可显示
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Valeant Pharmaceuticals 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Valeant Pharmaceuticals has issues with accounting and pricing practices.Before Bausch + Lomb, he was brought in as the CEO of Bausch (BHC.TO) in 2016 as the company, formerly called Valeant, sought to get past a flurry of investigations into its accounting and pricing practices under the previous management.
二月 20, 2024阅读更多
新闻Valeant Pharmaceuticals acquires AddyiTM for $1B.The day after the FDA approval, Valeant acquired Addyi for $1 billion.
十二月 16, 2022阅读更多
新闻Valeant Pharmaceuticals acquired Allergan PLC for $37M on Jan 1st '14.Valeant begin an endeavor to buy Allergan in 2012, but could not afford the $37 million cost, so it reached a deal with a hedge fund company called Pershing.
九月 6, 2022阅读更多
查看 Valeant Pharmaceuticals 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。